SARS-CoV-2 Total Ab Assay

Print
SARS-CoV-2 Total Ab

Overview

The Platelia SARS-CoV-2 Total Ab assay ensures reliable detection of anti-SARS-CoV-2 IgM, IgA and IgG in one test to determine the immune response to SARS-CoV-2.


Read full description

Ordering Information


Description

Request more information

The Platelia SARS-CoV-2 Total Ab assay ensures reliable detection of anti-SARS-CoV-2 IgM, IgA and IgG in one test to determine the immune response to SARS-CoV-2.

Accurate Performance

  • High specificity (>99%)
  • Excellent sensitivity allows for earlier identification of seroconversion and reliable screening
  • No cross-reactivity

Convenient & Fast

  • 1-step antigen capture format (only 90-minute incubation time required)
  • 96-well microplate testing with breakable strips
  • Ready to use with colored reagents
  • Visual control of sample dilution and reagent addition

In the U.S., the test has been authorized by the FDA under an EUA for use by authorized laboratories. The test has not been FDA cleared or approved. The test has been authorized only for the presence of total antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

This antibody test is for in vitro diagnostic use only by professionals in laboratories certified to perform high complexity tests.

Please contact your Bio-Rad local representative to check the availability in your country.


Ordering

x

Account price failed to display. Please try reloading the page.Reload Page

If you are placing an order, you may proceed with your order; the account price will be applied if it is lower than the
list price. If the problem persists, please call customer service at or send an
email to

Platelia SARS-CoV-2 Total Ab assay

12015289
Qualitative detection of antibodies IgM, IgA and IgG to
SARS-CoV-2 all in one test using EIA technology. Testing can be performed in human serum or plasma samples (96 tests).

List Price: 
 
Inquire
LoadingLoading...
EDU Price:
 
What is this?
Your Price: 
 
LoadingLoading...
Your Price:
 

Communication error

Reload Page

Quantity:  
 
Hazardous  
Platelia SARS-CoV-2 Total Ab assay

12015253
Qualitative detection of antibodies IgM, IgA and IgG to
SARS-CoV-2 all in one test using EIA technology. Testing can be performed in human serum or plasma samples (480 tests).

List Price: 
 
Inquire
LoadingLoading...
EDU Price:
 
What is this?
Your Price: 
 
LoadingLoading...
Your Price:
 

Communication error

Reload Page

Quantity:  
 
Hazardous  
Platelia SARS-CoV-2 Total Ab assay

72710

List Price: 
 
Inquire
LoadingLoading...
EDU Price:
 
What is this?
Your Price: 
 
LoadingLoading...
Your Price:
 

Communication error

Reload Page

Quantity:   Add to Cart
 
Hazardous  

Documents

Number Description Options
IFU-US_12015289_12015253EN IFU for Platelia SARS-CoV-2 Total Ab: 12015289,12015253 (English, November 2020) Click to download
IFU-ADD_12015289_12015253_providers Platelia SARS-CoV-2 Total Ab: Fact Sheet for Healthcare Providers Click to download
IFU-ADD_12015289_12015253_recipients Platelia SARS-CoV-2 Total Ab: Fact Sheet for Recipients Click to download

This product contains electrical or electronic material. Learn more about Bio-Rad's EU Recycle Program

Get Help
Sign Up for Bio-Rad Updates!
Enter your email address below to receive your choice of the latest news, promotions, and more.